Cite
HARVARD Citation
Shirouchi, Y. et al. (n.d.). PROGRESSION FREE SURVIVAL AT 12 MONTHS AFTER FIRST‐LINE THERAPY IS ASSOCIATED WITH FAVOURABLE OUTCOMES AFTER FIRST RELAPSE/PROGRESSION IN PERIPHERAL T‐CELL LYMPHOMA. Hematological oncology. pp. 469-470. [Online].